Thank you for completing the form. Your details are emailed to procurement@ebpf-uae.com
 

Download Tender Document

Close

To download the complete tender document please fill out the below form.

Tender Number Document Fees Subject Registration close
RFQ-10-0050 15,000
US Dollars
Supply of equipment for
Emirates Biotech
Pharmaceutical Factory L.L.C.
December
15th, 2010
Emirates Biotech Pharmaceutical Factory L.L.C. is inviting offers from all experienced suppliers to participate in this tender to provide the factory with the full range of equipment and accessories. Companies with intention to participate in bidding must pay A non-refundable fee of 15,000 US Dollars ( Fifteen Thousand US Dollars ) by December 15th, 2010. Bidders are welcome at the factory head offices in Abu Dhabi, Bain Al Jisrain, beside Mercedes service center.
   
For more information, please contact: USD Account Number:
Emirates Biotech Pharmaceutical Factory L.L.C.
Procurement Division
Saeed Yacoubi
+971.50.4128.094 / procurement@ebpf-uae.com
6501895850
Union National Bank
Abu Dhabi, United Arab Emirates
SWIFT: UNBEAEAA
   
Emirates Biotech Pharmaceutical Factory L.L.C. is based in Abu Dhabi. Planning to produce pharmaceutical raw material based on biotechnology process, it is the first company to have access to the technology in the Middle East.
The project is divided into two phases. The first phase – approximately 124 million USD – is the finished formulation products based on API growth hormones and other growth factors and Alpha/Beta Interferon and creating the facility to manufacture anti-cancer vaccines. The company has tied up with GL Rapha, Korea for technological assistance, manufacturing and marketing. Phase one will be completed by 2012.
The second phase – 117 million USD – is to produce API crystals insulin. Phase two will be completed by end of 2013 according to project plan.
Emirates Biotech Pharmaceutical Factory L.L.C. was established by prestigious founders, well renowned businessmen, and esteemed international partners. Emirates Biotech Pharmaceutical Factory L.L.C. has signed with GL Rapha and Hankook Corus Pharm, two pharmaceutical companies based in Seoul, South Korea, to construct the factory and market the products.
For more information about Emirates Biotech Pharmaceutical Factory L.L.C. please visit: www.ebpf-uae.com
List of buildings to equip
Animal Laboratory Building Guard House Building Anti-Biotics Building Bio API Building
Solutions Building Anti-Cancer Building Bio Finishing Building Ware House Building
Administration Building Central Utility Building Waste Water Treatment Building Empty Vial Building
Financial Partners Contact Information
Union National Bank Finance House
Head Office - Abu Dhabi, UAE
Mr. Adnan Al Mufti
Mobile: 00.971.50.818.2021
Tel: +971.2.674.1600
Fax: +971.2.678.6080
www.unb.co.ae
Head Office - Abu Dhabi, UAE
Mr. Ramesh Rajaram
Tel: +971 2 619 4000
Fax: +971 2 619 4099
www.fh.ae

Tender Terms & Conditions

  1. Quotations must be submitted no later than: 20th January, 2011
  2. All quotations must be submitted in a sealed envelope with red wax to:
    Procurement Division
    Emirates Biotech Pharmaceutical Factory L.L.C.
    Abu Dhabi, United Arab Emirates
  3. Your quotation must show currency quoted, price breakdown, total value for each building, grand total value, and quotation validity.
  4. Your base bid should be without deviation from our specifications however you are encouraged to propose any alternatives provided you clearly mark “ALTERNATIVE”
  5. Emirates Biotech Pharmaceutical Factory L.L.C. does not undertake to accept the lowest or any other Tender. While Emirates Biotech Pharmaceutical Factory L.L.C. presently intends to award a contract for the supply of the Goods, Emirates Biotech Pharmaceutical Factory L.L.C. reserves the right not to do so.
  6. Emirates Biotech Pharmaceutical Factory L.L.C. reserves the right to accept a part of any Tender and not necessarily-the Tender as a whole.
  7. Emirates Biotech Pharmaceutical Factory L.L.C. can accept quotations for a single building, several building, or all buildings (turnkey solutions).
  8. The acceptance by Emirates Biotech Pharmaceutical Factory L.L.C. of a Tender shall constitute a binding agreement between Emirates Biotech Pharmaceutical Factory L.L.C. and the successful tenderer. Such tenderer will be informed of the outcome of the Tender soon after a decision to enter into a Price Agreement is taken by Emirates Biotech Pharmaceutical Factory L.L.C. and will subsequently be required to sign a formal Price Agreement with Emirates Biotech Pharmaceutical Factory L.L.C.